Related Experiment Video
Updated: Aug 10, 2026
06:32
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
Proliferation markers as a tool in oncological neuropathology
1Dept. of Histology and Embryology, Medical Faculty, Charles University, Hradec Králové.
Sbornik Vedeckych Praci Lekarske Fakulty Karlovy University V Hradci Kralove
|January 1, 1995
Summary
Integrating cell proliferation kinetics data can improve brain tumor histoprognosis by reducing subjectivity. This review recommends reliable markers and techniques for evaluating tumor cell proliferation in neurooncology.
Area of Science:
- Neuro-oncology
- Tumor biology
- Histopathology
Background:
- Histological classification of brain tumors presents challenges for accurate prognosis.
- Subjectivity in tumor evaluation can be reduced by incorporating quantitative data.
Purpose of the Study:
- To review the literature on proliferation markers in neuro-oncology.
- To identify limitations of current methods and recommend reliable techniques.
Main Methods:
- Review of existing literature on cell proliferation markers.
- Discussion of methods including immunohistochemistry, silver staining, and flow cytometry.
- Evaluation of marker reliability and application in neuro-oncology.
Main Results:
- Various methods exist for measuring cell proliferation, each with inherent challenges.
- Immunohistochemical detection of pyrimidine analogues and cell cycle antigens are key techniques.
- Selective silver staining and modified flow cytometry offer alternative approaches.
Conclusions:
- Quantitative proliferation data integration is crucial for objective brain tumor histoprognosis.
- Reliable markers and standardized techniques are recommended for clinical use.
- Specific clinical situations warranting proliferation marker assessment are identified.
